We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

66 hedge funds and large institutions have $15.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 64 → 66 (+2)

17% less capital invested

Capital invested by funds: $18.4M → $15.3M (-$3.15M)

30% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 20

90% less call options, than puts

Call options by funds: $40K | Put options by funds: $397K

Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
14
Reduced
20
Closed
14
Calls
$40K
Puts
$397K
Net Calls
-$357K
Net Calls Change
-$2.04M

Top Buyers

1
TI
Turner Investments
Pennsylvania
+$671K
2
AllianceBernstein
AllianceBernstein
Tennessee
+$598K
3
Goldman Sachs
Goldman Sachs
New York
+$156K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$126K
5
HighTower Advisors
HighTower Advisors
Illinois
+$108K

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$1.44M
2
State Street
State Street
Massachusetts
-$661K
3
SFM
Sphera Funds Management
Israel
-$476K
4
BIT
BlackRock Institutional Trust
California
-$462K
5
DBG
De Burlo Group
Massachusetts
-$399K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$4.46M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.54M +$18.3K +17 +1%
TI
3
Turner Investments
Pennsylvania
$1.34M +$671K +622 +87%
AllianceBernstein
4
AllianceBernstein
Tennessee
$1.01M +$598K +555 +124%
BBA
5
Baker Bros. Advisors
New York
$930K – – –
Northern Trust
6
Northern Trust
Illinois
$535K -$59.3K -55 -9%
KCM
7
Knoll Capital Management
Florida
$515K – – –
SIP
8
Stoneridge Investment Partners
Pennsylvania
$326K +$102K +95 +41%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$284K -$44.2K -41 -13%
Millennium Management
10
Millennium Management
New York
$265K -$3.23K -3 -1%
SM
11
Sabby Management
Florida
$226K -$284K -263 -54%
GBA
12
Garrison Bradford & Associates
New York
$214K – – –
HF
13
Hoxton Financial
West Virginia
$207K – – –
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$198K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$182K +$20.5K +19 +12%
BFA
16
BlackRock Fund Advisors
California
$176K -$1.44M -1,334 -88%
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$174K – – –
LCM
18
Leisure Capital Management
California
$162K +$9.71K +9 +6%
CCB
19
Cutter & Co Brokerage
Missouri
$149K +$27K +25 +20%
Goldman Sachs
20
Goldman Sachs
New York
$146K +$156K +145 New
ARTA
21
A.R.T. Advisors
New York
$141K +$65.8K +61 +76%
TCIM
22
TIAA CREF Investment Management
New York
$136K -$50.7K -47 -26%
FNBT
23
FineMark National Bank & Trust
Florida
$132K +$80.9K +75 +134%
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$123K +$22.6K +21 +21%
COPPSERS
25
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$118K +$126K +117 New
1
2 3 4

NBSE Hedge Fund Activity: Q2 2015 in Review

66 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2015, worth a combined $15.3M — down 17% from $18.4M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NBSE positions and 14 closed out — a net gain of 2 holders — while 14 added to existing stakes and 20 trimmed.

The largest buyer was Turner Investments, adding an estimated $671K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.44M.

  • 66 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2015, up from 64 in Q1 2015.
  • Funds reported $15.3M of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2015, down 17% quarter-over-quarter.
  • 16 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2015 and 14 closed out, a net change of +2 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q2 2015 was Turner Investments, an estimated $671K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.44M sold.

Based on aggregated 13F filings for Q2 2015.